Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00141388 · ClinicalTrials.gov registry record · Phase 3
To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures
A Phase 3 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 3
- Development phase
- 455
- Enrollment target
NCT00141388 is a Phase 3 study that has completed, run by Pfizer. The registered enrollment target is 455 participants.
The verdict
NCT00141388, a Phase 3 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 455 participants
- Enrollment target
Study Summary
To evaluate the long-term safety and efficacy of pregabalin in patients with partial seizures.
Interventions
- DRUG Pregabalin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 455 participants |
| Start Date | 1998-07 |
| Est. Completion | 2005-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00141388
The ClinicalTrials.gov registry entry for NCT00141388 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 455 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pregabalin is the first listed.
NCT00141388 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00141388 about?
NCT00141388 is a clinical study titled "To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures". To evaluate the long-term safety and efficacy of pregabalin in patients with partial seizures.
What is the current status of trial NCT00141388?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 455 participants. The study started on 1998-07. Estimated completion is 2005-10.
What interventions are being tested in trial NCT00141388?
The interventions under investigation include: Pregabalin (DRUG).
Who is sponsoring clinical trial NCT00141388?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.